Product Details

Jyna Darunavir Tablets 600 mg##

Emtricitabine; Tenofovir Disoproxil Fumarate
200 mg; 300 mg
Tablet

ROA

Oral

Applicant Name

Jyna Pharma Ltd

NRN

A4-100044

Status

Active


Composition

Each film coated tablet contains: Emtricitabine 200 mg, Tenofovir disoproxil fumarate 300 mg equivalent to Tenofovir disoproxil 245 mg This medicinal product contains Lactose (Anhydrous) 145 mg in core and 8.40 mg (28.0 % of 30 mg) in the film coat of Lactose Monohydrate  

ATC Code

J05AR03  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 x 30's, 1 x 90's (in HDPE bottles)  

Product Description

Film coated tablet Blue colored, capsule shaped, film-coated biconvex tablets, debossed with “LA49” on one side and plain on the other side JYNA DARUNAVIR TABLETS 600 MG A4-100044 DARUNAVIR TABLETS 600 MG EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE ANTI-INFECTIVES ORAL 200 MG, 300 MG TABLET, FILM COATED PRESCRIPTION ONLY MEDICINE (POM) "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS ARE INDICATED IN ANTIRETROVIRAL COMBINATION THERAPY FOR THE TREATMENT OF HIV-1 INFECTED ADULTS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS ARE ALSO INDICATED FOR THE TREATMENT OF HIV-1 INFECTED ADOLESCENTS, WITH NRTI RESISTANCE OR TOXICITIES PRECLUDING THE USE OF FIRST LINE AGENTS ." JYNA PHARMA LTD NIGERIA LAURUS LABS INDIA 2021-05-07 2026-05-06

Manufacturer Name

Laurus Labs Limited

Manufacturer Country

INDIA  

Approval Date

2021-05-07  

Expiry Date

2026-05-06